Impel NeuroPharma raises $36M for drug delivery platform that bypasses blood-brain barrier by Clare McGrane on December 3, 2016December 3, 2016 at 6:21 am Impel NeuroPharma, a Seattle-based biotechnology and pharmaceutical company, announced a $36 million Series C round to develop neurological drugs and an accompanying delivery device that bypasses the blood-brain barrier. The… Read More